Skip to search form
Skip to main content
>
Semantic Scholar
Semantic Scholar's Logo
Search
Sign In
Create Free Account
You are currently offline. Some features of the site may not work correctly.
bozepinib
National Institutes of Health
Create Alert
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Enhancement of Tumor Cell Death by Combining gef Gene Mediated Therapy and New 1,4-Benzoxazepin-2,6-Dichloropurine Derivatives in Breast Cancer Cells
A. Ramírez
,
A. Conejo-García
,
+5 authors
H. Boulaiz
Front. Pharmacol.
2018
Corpus ID: 50784143
New treatment modalities are urgently needed to better manage advanced breast cancer. Combination therapies are usually more…
Expand
2017
2017
1-(Benzenesulfonyl)-1,5-dihydro-4,1-benzoxazepine as a new scaffold for the design of antitumor compounds.
O. Cruz-López
,
A. Ramírez
,
+4 authors
A. Conejo-García
Future medicinal chemistry
2017
Corpus ID: 10238667
AIM Bozepinib is a potent and selective anticancer compound which chemical structure is made up of a benzofused seven-membered…
Expand
2014
2014
HER2-signaling pathway, JNK and ERKs kinases, and cancer stem-like cells are targets of Bozepinib
A. Ramírez
,
H. Boulaiz
,
+10 authors
J. A. Marchal
Oncotarget
2014
Corpus ID: 18027888
Identification of novel anticancer drugs presenting more than one molecular target and efficacy against cancer stem-like cells…
Expand
2013
2013
Bozepinib, a novel small antitumor agent, induces PKR-mediated apoptosis and synergizes with IFNα triggering apoptosis, autophagy and senescence
J. A. Marchal
,
E. Carrasco
,
+8 authors
M. Á. García
Drug design, development and therapy
2013
Corpus ID: 1547658
Bozepinib [(RS)-2,6-dichloro-9-[1-(p-nitrobenzenesulfonyl)-1,2,3,5-tetrahydro-4,1-benzoxazepin-3-yl]-9H-purine] is a potent…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
,
Terms of Service
, and
Dataset License
ACCEPT & CONTINUE